Tameridone

This classification denotes a sedative and hypnotic with the molecular formula C22H26N6O2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 74ATQ0K1LA, chemically known as 1h-purine-2,6-dione, 3,7-dihydro-7-(2-(4-(1h-indol-3-yl)-1-piperidinyl)ethyl)-1,3-dimethyl- but generally known as tameridone, which bears US NIH Compound Identifier 71304. European Medicines Agency schedules Tameridone in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10819MIG. The term TAMERIDONE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 1, No. 4, 1987, List 27). TAMERIDONE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule tameridone under HS 29395900 and SITC 54145. As of Q4 2014, TAMERIDONE remains the US FDA Preferred Term for this commodity. Tameridone bears US NLM identifiers UMLS ID C2699889 and NCI Concept Code C76946. SMILES: O=C1N(C(=O)N(C2NCN(CCN3CCC(CC3)C3C4C([NH]C3)CCCC4)C12)C)C.